Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > SPECIFIC CANCERS > COLORECTALUK treatment guidelines - Colorectal cancer
- Laparoscopic surgery for colorectal cancer - NICE, August 2006
- Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer - NICE, April 2006
- Cancer service guidance: Improving outcomes in colorectal cancer - NICE, June 2004
- Management of Colorectal Cancer - A National Clinical Guideline - SIGN, 2003
- The clinical effectiveness and cost effectiveness of capecitabine and tegafur uracil for colorectal cancer - NICE, May 2003
- Guidelines for the Management of Colorectal Cancer - Association of Coloproctology of Great Britain and Ireland, 2001
- Handbook for the clinico-pathological assessment and staging of colorectal cancer - UKCCCR, 1997
- Colonoscopy or double contrast barium enema for detecting cancer of the colon - Wessex Institute 1994
Laparoscopic surgery for colorectal cancer - NICE, August 2006
Produced by: NICE - National Institute for Health and Clinical Excellence. Technology Appraisal TA105.
Purpose: Update on guidance to the NHS on when laparoscopic surgery (including laparoscopically assisted surgery) is recommended as an alternative to open surgery for people with colorectal cancer. Replaces Technology Appraisal 17 (December 2000).
Can be obtained from: Full guidance, quick reference guide and public information leaflet can be downloaded from the website.
Link to website: www.nice.org.uk/guidance/TA105
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer - NICE, April 2006
Produced by: National Institute for Health and Clinical Excellence (NICE), April 2006. Technology Appraisal TA100.
Purpose: Guidance for the NHS about when capecitabine and oxaliplatin are recommended as possible adjuvant treatments after surgery for stage III (Dukes’ C) colon cancer.
Obtain from: The full guidance, quick reference guide and public information leaflet are available to download from the website.
Link to website: www.nice.org.uk/guidance/TA100
Cancer service guidance: Improving outcomes in colorectal cancer - NICE, June 2004
Produced by: National Institute for Clinical Excellence (NICE). June 2004.
Purpose: Service Guidance for the NHS in England and Wales Improving Outcomes for Colorectal cancer (Update). The Colorectal Cancer Service Guidance is an update of the publication 'Improving Outcomes in Colorectal Cancer' published by the Department of Health in November 1997.
Can be obtained from: Copies of this document are available from the NICE website or from the NHS Response Line (telephone 0870 1555 455). The Guidance manual, Guidance on Cancer Services – Improving Outcomes in Colorectal Cancer: Manual Update (reference N0555) and a CD with all documentation including the research evidence on which the guidance is based (reference N0556) are also available.
Link to website: www.nice.org.uk/guidance/CSGCC
Management of Colorectal Cancer - A National Clinical Guideline - SIGN, 2003
Produced by: Scottish Intercollegiate Guidelines Network (SIGN) - March 2003 No.67
Purpose: To draw up a guideline for the management of colorectal cancer.
Can be obtained from: SIGN Secretariat, 9 Queen Street, Edinburgh EH2 1JQ. Tel: 0131 225 7324.
Link to website (PDF document)
You need Adobe Acrobat Reader software to view PDF files. You can download it for free from the Adobe website.
The clinical effectiveness and cost effectiveness of capecitabine and tegafur uracil for colorectal cancer - NICE, May 2003
Produced by: National Institute for Clinical Excellence (NICE), May 2003. Technology Appraisal TA061.
Purpose: Guidance providing a review of clinical and economic evidence leading to recommendations on the appropriate use of new and existing medicines and treatments in the treatment of colorectal cancer.
Can be obtained from: Copies of this guidance can be obtained from the NHS Response Line by telephoning 0870 1555 455 and quoting ref: N0221 A patient version of this document can be obtained by quoting ref: N0223. A bi-lingual patient leaflet is also available, ref: N0224.
Link to website: www.nice.org.uk/guidance/TA61
Guidelines for the Management of Colorectal Cancer - Association of Coloproctology of Great Britain and Ireland, 2001
Produced by: Royal College of Surgeons of England and the Association of Coloproctology - Association of Coloproctology of Great Britain and Ireland 2001
Purpose: To assist clinicians in clinical decision making and practice.
Can be obtained from: Association of Coloproctology of Great Britain and Ireland, Royal College of Surgeons of England, 35-43 Lincoln Inn Fields, London WC2A 3PN. Tel: 020 7312 6682.
Link to website (PDF document)
Handbook for the clinico-pathological assessment and staging of colorectal cancer - UKCCCR, 1997
Produced by: UK Co-ordinating Committee on Cancer Research - 1997
Purpose: To provide recommendations to standardise the clinico-pathological assessment of patients with colorectal cancer.
Can be obtained from: UKCCCR, PO Box 123, Lincoln's Inn Fields, London WC2A 3PX.
Colonoscopy or double contrast barium enema for detecting cancer of the colon - Wessex Institute 1994
Produced by: Wessex Institute for Health Research & Development - 1994
Purpose: To provide rapid, accurate and usable information on health technology effectiveness to purchasers, clinicians, managers and researchers.
Can be obtained from: Wessex Institute for Health Research and Development, Boldrewood, Southampton University, Southampton SO16 7PX. Ref: 94/5.
Link to website: www.hta.nhsweb.nhs.uk/rapidhta/publications.htm
Content last reviewed: 01 September 2006
Page last modified: 04 April 2007
Page last modified: 04 April 2007